In Vitro Techniques
A robust method to identify compounds that undergo intracellular lysosomal sequestration
Faraz Kazmi, XenoTech, LLC;
Ryan Funk, University of Kansas;
Chad Pope, XenoTech, LLC;
Maciej Czerwinski, XenoTech, LLC;
David Buckley, XenoTech, LLC;
Andrew Parkinson, XenoTech, LLC
An Improved Approach to Characterize Unbound Drug Concentrations
David A. Erickson, Covance Labs Inc;
Kari Landsverk, Covance Labs Inc;
Nicole Engh, Covance Labs Inc;
Kristen Cardinal, Covance Labs Inc;
Michele Hamrick, Covance Labs Inc;
Kristine Horabik, Covance Labs Inc;
Jody Wanta, Covance Labs Inc;
Richard Ridgewell, Covance Labs Inc
CHARACTERIZATION OF A HUMAN HEPATOCELLUAR CARCINOMA CELL LINE ON MICRO-SPACE CELL CULTURE PLATE
Yoko Ejiri, Kuraray Co., Ltd.;
Akane Yoshida, Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Chiba University;
Masaya Hosoda, Kuraray Co., Ltd.;
Kaoru Kobayashi, Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Chiba University;
Kan Chiba, Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Chiba University
Evaluating the potential for lysosomal trapping in immortalized human hepatocytes (Fa2N-4 cells)
Tiffini Hensley, XenoTech, LLC;
Greg J. Loewen, XenoTech, LLC;
Faraz Kazmi, XenoTech, LLC;
Brian Ogilvie, XenoTech, LLC;
David Buckley, XenoTech, LLC;
Andrew Parkinson, XenoTech, LLC
In Vitro Reactivity Assessment of Covalent Drugs Targeting Bruton's Tyrosine Kinase
Matthew Labenski, Avila Therapeutics;
Prasoon Chaturvedi, Avila Therapeutics;
Erica Evans, Avila Therapeutics;
Hormoz Mazdiyazni, Avila Therapeutics;
Michael Sheets, Avila Therapeutics;
Sharon Aslanian, Avila Therapeutics;
Mariana Nacht, Avila Therapeutics;
Russell Petter, Avila Therapeutics;
Juswinder Singh, Avila Therapeutics;
William Westlin, Avila Therapeutics
![[ Visit Client Website ]](images/banner.gif)